Success Metrics

Clinical Success Rate
87.5%

Based on 14 completed trials

Completion Rate
88%(14/16)
Active Trials
2(9%)
Results Posted
21%(3 trials)
Terminated
2(9%)

Phase Distribution

Ph early_phase_1
2
9%
Ph phase_2
6
26%
Ph phase_1
4
17%
Ph phase_3
1
4%
Ph not_applicable
3
13%
Ph phase_4
5
22%

Phase Distribution

6

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
2(9.5%)
Phase 1Safety & dosage
4(19.0%)
Phase 2Efficacy & side effects
6(28.6%)
Phase 3Large-scale testing
1(4.8%)
Phase 4Post-market surveillance
5(23.8%)
N/ANon-phased studies
3(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

14 of 18 finished

Non-Completion Rate

22.2%

4 ended early

Currently Active

2

trials recruiting

Total Trials

23

all time

Status Distribution
Active(3)
Completed(14)
Terminated(4)
Other(2)

Detailed Status

Completed14
Withdrawn2
unknown2
Terminated2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
23
Active
2
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (9.5%)
Phase 14 (19.0%)
Phase 26 (28.6%)
Phase 31 (4.8%)
Phase 45 (23.8%)
N/A3 (14.3%)

Trials by Status

recruiting14%
not_yet_recruiting14%
completed1461%
withdrawn29%
active_not_recruiting14%
unknown29%
terminated29%

Recent Activity

2 active trials
Showing 5 of 23
not_yet_recruitingphase_2

Pilot Study: Effects of Nimodipine on Alcohol Drinking

NCT06900998
completedphase_3

Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning

NCT03925025
active_not_recruitingearly_phase_1

Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity

NCT04923659
recruitingnot_applicable

Perioperative Intravenous Nimodipine Trial

NCT07048522
unknown

Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial Administration

NCT04649398
View all 23 trials

Clinical Trials (23)

Showing 20 of 23 trialsScroll for more
NCT06900998Phase 2

Pilot Study: Effects of Nimodipine on Alcohol Drinking

Not Yet Recruiting
NCT03925025Phase 3

Effectiveness of Calcium Channel Blockade for OP and Carbamate Pesticide Poisoning

Completed
NCT04923659Early Phase 1

Pharmacological Mechanisms of Low-intensity Focused Ultrasound for Motor Cortex Neuroplasticity

Active Not Recruiting
NCT07048522Not Applicable

Perioperative Intravenous Nimodipine Trial

Recruiting
NCT04649398

Cerebral Nimodipine Concentrations Following Oral, Intra-venous and Intra-arterial Administration

Unknown
NCT03671525Early Phase 1

Cognitive Effects of Nimodipine in Patients With Schizophrenia

Completed
NCT04100824Phase 2

Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

Completed
NCT05131867Phase 2

Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy

Completed
NCT00000738Phase 1

Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1

Completed
NCT01672801Not Applicable

Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT

Completed
NCT03150524Phase 4

RCVS: The Rational Approach to Diagnosis and Treatment

Withdrawn
NCT02991157

Noninvasive Assessment of Cerebral Oxygenation and Cardiac Function in Patients With Neurovascular Diseases

Completed
NCT01551368Phase 2

Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients

Terminated
NCT02248233Phase 4

Nimodipine for Treating Acute Massive Cerebral Infarction

Completed
NCT01893190Phase 1

Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage

Completed
NCT00000280Phase 1

Glutaminergic Agents for Cocaine Abuse - 5

Completed
NCT00000332Phase 2

High Dose Nimodipine Treatment Adjunct - 1

Completed
NCT00781326Phase 4

Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression

Terminated
NCT01835665Phase 1

Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations

Completed
NCT02165644Phase 2

Carbonic Anhydrase Antagonism in Subarachnoid Hemorrhage

Withdrawn

Drug Details

Intervention Type
DRUG
Total Trials
23